News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
264,701 Results
Type
Article (14114)
Company Profile (283)
Press Release (250304)
Section
Business (79517)
Career Advice (152)
Deals (13232)
Drug Delivery (35)
Drug Development (50417)
Employer Resources (31)
FDA (5707)
Job Trends (5126)
News (144393)
Policy (10034)
Tag
Academia (905)
Alliances (21621)
Alzheimer's disease (797)
Antibody-drug conjugate (ADC) (75)
Approvals (5709)
Artificial intelligence (93)
Bankruptcy (102)
Best Places to Work (4562)
Biotechnology (232)
Breast cancer (130)
Cancer (1112)
Cardiovascular disease (88)
Career advice (132)
CAR-T (92)
Cell therapy (272)
Clinical research (40575)
Collaboration (437)
Compensation (184)
COVID-19 (1024)
C-suite (117)
Cystic fibrosis (74)
Data (1151)
Diabetes (105)
Diagnostics (1280)
Earnings (29218)
Events (47685)
Executive appointments (353)
FDA (6213)
Funding (414)
Gene editing (76)
Gene therapy (199)
GLP-1 (338)
Government (1073)
Healthcare (6572)
Infectious disease (1075)
Inflammatory bowel disease (105)
IPO (7250)
Job creations (859)
Job search strategy (127)
Layoffs (196)
Legal (1383)
Lung cancer (164)
Manufacturing (103)
Medical device (2585)
Medtech (2586)
Mergers & acquisitions (6218)
Metabolic disorders (315)
Neuroscience (1111)
NextGen: Class of 2025 (2013)
Non-profit (856)
Northern California (1342)
Obesity (166)
Opinion (96)
Parkinson's disease (89)
Patents (86)
People (25387)
Phase I (14316)
Phase II (18877)
Phase III (11935)
Pipeline (504)
Postmarket research (853)
Preclinical (5997)
Radiopharmaceuticals (209)
Rare diseases (248)
Real estate (1417)
Regulatory (8447)
Research institute (932)
Series A (82)
Southern California (1193)
Startups (1969)
United States (10543)
Vaccines (189)
Weight loss (96)
Date
Today (5)
Last 7 days (340)
Last 30 days (1462)
Last 365 days (20390)
2025 (2648)
2024 (20573)
2023 (22429)
2022 (26833)
2021 (27813)
2020 (23365)
2019 (16243)
2018 (11747)
2017 (13752)
2016 (11847)
2015 (14358)
2014 (10397)
2013 (7494)
2012 (7541)
2011 (7621)
2010 (7433)
Location
Africa (148)
Asia (17107)
Australia (2894)
California (3056)
Canada (965)
China (269)
Colorado (115)
Connecticut (130)
Delaware (72)
Europe (36804)
Florida (348)
Georgia (91)
Illinois (192)
Indiana (73)
Maryland (397)
Massachusetts (2385)
Minnesota (119)
New Jersey (762)
New York (835)
North Carolina (475)
Northern California (1342)
Ohio (98)
Pennsylvania (577)
South America (207)
Southern California (1193)
Texas (337)
Washington State (291)
264,701 Results for "gemini therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Revelation Biosciences Starts its PRIME Phase 1b Clinical Study of Gemini in CKD Patients
January 21, 2025
·
6 min read
Press Releases
Revelation Biosciences Inc. Announces FDA Acceptance of Gemini IND
December 3, 2024
·
5 min read
Press Releases
Revelation Biosciences, Inc. Completes the GMP Manufacture of Gemini Clinical Drug Supply
November 12, 2024
·
4 min read
Drug Development
Revelation Biosciences Announces Phase 1 Clinical Study of Gemini Met the Primary Safety Endpoint and Showed Statistically Significant Biomarker Activity
Revelation Biosciences Announces Phase 1 Clinical Study of Gemini Met the Primary Safety Endpoint and Showed Statistically Significant Biomarker Activity.
June 24, 2024
·
9 min read
Drug Development
Anaptys Announces Positive Top-Line GEMINI-2 Phase 3 Clinical Trial Results of Imsidolimab (IL-36R) in Generalized Pustular Psoriasis (GPP)
AnaptysBio, Inc. announced positive top-line results from its global GEMINI-1 and GEMINI-2 Phase 3 trials evaluating the safety and efficacy of investigational imsidolimab in patients with generalized pustular psoriasis, a severe orphan disease that is potentially life-threatening if left untreated.
May 9, 2024
·
7 min read
Press Releases
Gemini Bioproducts, LLC Acquires Selected Fetal Bovine Serum (FBS) Product Rights and Inventory from Bio-Techne
November 25, 2024
·
3 min read
Drug Development
Revelation Biosciences Inc. Announces Commencement of First in Human Phase 1 Clinical Study of Gemini
Revelation Biosciences Inc. Announces Commencement of First in Human Phase 1 Clinical Study of Gemini.
March 4, 2024
·
5 min read
Press Releases
Revelation Biosciences’ Gemini Induces Dose Dependent Significant Increases in IL-10
September 24, 2024
·
7 min read
Deals
Disc Medicine Announces Completion of Merger with Gemini Therapeutics
Disc Medicine, Inc. announced that its previously-announced merger with Gemini Therapeutics, Inc. closed on December 29, 2022, following the approval of Gemini shareholders.
December 29, 2022
·
8 min read
Drug Development
Revelation Biosciences Has Completed Dosing of its First in Human Phase 1 Clinical Study of Gemini
Revelation Biosciences, Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a clinical-stage life sciences company that is focused on harnessing the power of trained immunity for the prevention and treatment of disease, announced today that it has completed enrollment and dosing of its first in human Phase 1 clinical study (RVL-HV02).
June 13, 2024
·
5 min read
1 of 26,471
Next
